Skip to main navigation Skip to search Skip to main content

A phase III trial of marizomoib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

Klinische Prüfung eines nicht registrierten Arzneimittels
Short titleEORTC-1709-BTG
StatusFinished
Effective start/end date03.07.2019 → 13.09.2022

Fields of science

  • 302052 Neurology
  • 302058 Palliative medicine
  • 302055 Oncology
  • 302030 Internal medicine